Start an analysis for ONCO
Onconetix, Inc.
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $375.0kEST | 30-Sep-26 | 10-Q filed 16-Nov-26 |
| Remaining authorization | Not found in filings | — | |
| Program expiry | n/a | — | |
| Repurchased last quarter | Not found in filings | — | |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 10-Nov-22 | $375.0kEST 125,000 sh | Not found in filings | n/a | On November 10, 2022, the Board approved a stock repurchase program (the “Repurchase Program”) to allow the Company to repurchase up to 125,000 shares of common stock with a maximum price of $ 1.00 per share, with discretion to management to make purchases subject to market conditions.10-Q filed 16-Nov-26 |
Open-market repurchases
None reported in the filings we hold.